N-(7-(1H-imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl)benzamide - a new kainate receptor selective antagonist and analgesic: Synthesis, X-ray crystallography, structure-affinity relationships, in vitro and in vivo pharmacology

Stine Møllerud, Rie B Hansen, Jakob S Pallesen, Piero Temperini, Diletta Pasini, Jan Bornholdt, Birgitte Nielsen, Esmira Mamedova, Paulina Chalupnik, Ana V Paternain, Juan Lerma, Marta Diaz Del Castillo, Jesper T Andreasen, Karla Frydenvang, Jette Sandholm Kastrup, Tommy N Johansen, Darryl S Pickering

Protein Structure and Function Program
Motor Control

Fingerprint

Dive into the research topics of 'N-(7-(1H-imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl)benzamide - a new kainate receptor selective antagonist and analgesic: Synthesis, X-ray crystallography, structure-affinity relationships, in vitro and in vivo pharmacology'. Together they form a unique fingerprint.

Sort by
Weight
Alphabetically

N-(7-(1H-imidazol-1-yl)-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl)benzamide - a new kainate receptor selective antagonist and analgesic: Synthesis, X-ray crystallography, structure-affinity relationships, in vitro and in vivo pharmacology

Fingerprint

Medicine & Life Sciences

Chemical Compounds